SR9009 is a research drug that was developed by Professor Thomas Burris of the Scrips Research Institute as an agonist of Rev-ErbA.
SR9009 is presently under development at TSRI has been shown to considerably boost exercise endurance in animal models. Scientists think these discoveries may improvedcures for individuals suffering from illnesses that severely limit exercise endurance such as obesity, COPD (chronic obstructive pulmonary disease), congestive heart failure and also in the deterioration of muscle capacity linked with aging.
SR9009 is an easy to do oral compound can increase the level of metabolic activity in skeletal muscle of mice. The treated mice became lean, developed larger muscles and had a 50% increase in running abilities which imitates the effects of aerobic exercise.
If there is anything you wanna know , pls feel free to contact
E-mail:yana@ycphar.com
skype:yici1996
whatsapp:8618108459365
Name: SR9009 Synonyms: Stenabolic CAS No.: 1379686-30-2 Molecular formular: C20H24ClN3O4S Molecular Weight: 437.94 Appearance: White powder Purity: 99% Application: SR9009 increase exercise endurance and loss weight. ...
Product Name: SR9009(Stenabolic ) CAS:1379686-30-2 MF:C20H24ClN3O4S MW:437.94026 Appearance: White powder Purity: 99.% min Package: 10g/bag or as customers\'request. Test Method: HPLC Benefit:Stenabolic (SR9009) possesses the capabilities of reducing obesity as well as ...
Whatsapp:+86 188 3295 9082 +86 199 1301 0653 Mail:1046490047@qq.com hbbocao@gmail.com Facebook:18832959082 We chat:18832959082 QQ:1046490047 Skype:1046490047@qq.com name CAS NO MK677 159752-10-0 YK11 1370003-76-1 S23 1010396-29-8 GW0742 317318-84-6 SR9011 1379686-29-9 ...